AI Prior Authorization Automation: How Health Plans Cut Turnaround from 7 Days to 4 Hours While Hitting 99.8% CMS Compliance
How Rohnium's AXIOM platform auto-adjudicates 60% of PA volume with zero clinical reviewer time and why the difference is measured in hours, compliance rates, and $30M–$43M in annual savings.
It is Monday morning. Your clinical reviewers open their queues to 400-plus prior authorization requests; faxes, portal uploads, PDF exports from a dozen EHR systems, some barely legible.
Buried in a 30-page submission is the one detail that determines whether a patient starts treatment this week or waits another ten days.
Now add a clock. Under CMS-0057-F: 72 hours for expedited decisions, 7 days for standard requests. Miss those timelines and the consequences are immediate: compliance risk, audit exposure, declining CMS star ratings.
This is the operational reality AI prior authorization automation was built to solve; first as a compliance necessity, then as a competitive advantage.
Buried in a 30-page submission is the one detail that determines whether a patient starts treatment this week or waits another ten days.
Now add a clock. Under CMS-0057-F: 72 hours for expedited decisions, 7 days for standard requests. Miss those timelines and the consequences are immediate: compliance risk, audit exposure, declining CMS star ratings.
This is the operational reality AI prior authorization automation was built to solve; first as a compliance necessity, then as a competitive advantage.
The Operational Gap Between Manual PA Processing and CMS Compliance
Clinical reviewers spend 60 to 70 percent of their time on administrative work, such as data extraction, manual entry, and tracking down missing records, rather than clinical judgment. The actual review, the part that requires a licensed clinician, is often the smallest slice of the day.
Routine cases average 3 to 7 days. Complex cases run 10 to 14. Against a 72-hour federal clock, manual processing timelines create a compliance gap that compounds with every delayed decision.
AXIOM resolves this through automated deadline tracking, complete decision documentation, and consistent guideline application, achieving 99.8% CMS timely decision compliance versus 82% pre-deployment.
Legacy rule engines handle clean, simple submissions. The majority of what lands in a real queue arrives incomplete, ambiguous, or buried in formats that rule-based systems were designed to read around. Healthcare prior authorization software in 2026 has to operate at a fundamentally different level of clinical intelligence. Beyond rule-matching. Actual clinical reasoning.
Routine cases average 3 to 7 days. Complex cases run 10 to 14. Against a 72-hour federal clock, manual processing timelines create a compliance gap that compounds with every delayed decision.
AXIOM resolves this through automated deadline tracking, complete decision documentation, and consistent guideline application, achieving 99.8% CMS timely decision compliance versus 82% pre-deployment.
Legacy rule engines handle clean, simple submissions. The majority of what lands in a real queue arrives incomplete, ambiguous, or buried in formats that rule-based systems were designed to read around. Healthcare prior authorization software in 2026 has to operate at a fundamentally different level of clinical intelligence. Beyond rule-matching. Actual clinical reasoning.
What Clinical Reasoning Actually Requires and What Genuine PA Intelligence Delivers
Most PA tools on the market do one thing well: they find words in documents. Flag a CPT code. Locate "biopsy" in a physician note.
Clinical intelligence operates at a fundamentally different level.
When a rheumatologist submits a specialty biologic request, the question is whether this specific patient with this treatment history, this disease activity score, these safety labs, meets medical necessity criteria under this member's plan.
That requires understanding that three sequential DMARD regimens over ten months, each with documented inadequate response, constitute a completed step therapy pathway. That a DAS28 score of 5.2 signals high disease activity. That TB test, hepatitis panel, and liver function results must be current and present across a 34-page fax containing seven different document types.
That is a medical necessity review AI problem. Machine learning prior authorization processing, done correctly, solves it. OCR operates at a different level entirely.
That requires understanding that three sequential DMARD regimens over ten months, each with documented inadequate response, constitute a completed step therapy pathway. That a DAS28 score of 5.2 signals high disease activity. That TB test, hepatitis panel, and liver function results must be current and present across a 34-page fax containing seven different document types.
That is a medical necessity review AI problem. Machine learning prior authorization processing, done correctly, solves it. OCR operates at a different level entirely.
How AXIOM's Four Platforms Bring Clinical Intelligence to Every Prior Authorization Decision
AXIOM deploys four specialized platforms each with dedicated agents working in orchestrated collaboration across the complete prior authorization journey.
Document intelligence: Scriptus
Scriptus transforms unstructured clinical documentation into decision-ready intelligence. It reads medical records, physician notes, and test results in any format, interpreting ICD-10, CPT, and SNOMED terminology and extracting the specific clinical findings that support medical necessity.
That 34-page rheumatologist fax becomes seven correctly identified document types, clinically relevant data extracted from each, at 99-plus percent accuracy, even from poor-quality fax submissions.Incomplete submissions are flagged automatically before they consume reviewer time.
That 34-page rheumatologist fax becomes seven correctly identified document types, clinically relevant data extracted from each, at 99-plus percent accuracy, even from poor-quality fax submissions.Incomplete submissions are flagged automatically before they consume reviewer time.
Clinical reasoning: Vitalics
Vitalics analyzes the full clinical picture before a reviewer ever opens a case, delivering medical necessity review AI at its highest value. It analyzes the member's complete claims history, applies evidence-based medical policy criteria in real time, and builds a comprehensive member health profile.
For the rheumatoid arthritis case: step therapy verified against pharmacy claims, DAS28 score extracted and contextualized, all six safety screening results confirmed, and every criterion evaluated. What previously took a pharmacist 2 to 3 hours of active review arrives as a decision-ready summary; evidence cited, criteria mapped, clinical question clearly identified.
For the rheumatoid arthritis case: step therapy verified against pharmacy claims, DAS28 score extracted and contextualized, all six safety screening results confirmed, and every criterion evaluated. What previously took a pharmacist 2 to 3 hours of active review arrives as a decision-ready summary; evidence cited, criteria mapped, clinical question clearly identified.
Workflow automation: Flux
Flux is the engine that makes automated prior authorization processing operate at health plan scale. It receives requests across every channel simultaneously, routes by clinical complexity and specialty, and auto-adjudicates cases meeting clear criteria with zero clinical reviewer time.
Pre-AXIOM: 15 percent auto-approval rate.
With AXIOM: 60 percent, nearly half of the total PA volume handled, documented, and closed autonomously. A routine sports injury MRI resolves in under 10 minutes at $8 versus $75 with manual clinical review. For cases requiring human review, the reviewer receives a structured summary with the specific clinical question clearly identified; evidence pre-evaluated, criteria mapped, judgment ready to apply.
Pre-AXIOM: 15 percent auto-approval rate.
With AXIOM: 60 percent, nearly half of the total PA volume handled, documented, and closed autonomously. A routine sports injury MRI resolves in under 10 minutes at $8 versus $75 with manual clinical review. For cases requiring human review, the reviewer receives a structured summary with the specific clinical question clearly identified; evidence pre-evaluated, criteria mapped, judgment ready to apply.
Provider and leadership interface: Sage
Sage eliminates the friction that costs physicians 14-plus hours weekly on prior authorization paperwork. It enables providers to submit requests and check real-time prior authorization status through natural language: zero phone calls, zero fax confusion, zero repeated status inquiries.
Peer-to-peer coordination is managed directly through Sage, eliminating the week-long scheduling delays that postpone necessary clinical dialogue. For health plan leadership, Sage surfaces authorization patterns, approval rates, and denial trends in real time. When providers receive same-day decisions and real-time prior authorization status updates, the relationship shifts from administrative friction to clinical trust, and consistent, transparent, evidence-based decisions make advanced provider arrangements a realistic operational conversation.
Peer-to-peer coordination is managed directly through Sage, eliminating the week-long scheduling delays that postpone necessary clinical dialogue. For health plan leadership, Sage surfaces authorization patterns, approval rates, and denial trends in real time. When providers receive same-day decisions and real-time prior authorization status updates, the relationship shifts from administrative friction to clinical trust, and consistent, transparent, evidence-based decisions make advanced provider arrangements a realistic operational conversation.
What AXIOM Delivers Across Every Prior Authorization Metric That Matters
AXIOM vs. Traditional Prior Authorization: Performance Comparison
Total annual savings: $30 million to $43 million across administrative cost reduction, clinical staff optimization, avoided inappropriate approvals, and appeal cost savings.
Every decision is documented. Every clinical rationale is recorded. Every guideline application is auditable by default.
For Medical Directors specifically, reviewer productivity more than doubles from 15 to 20 cases per day to 35 to 45. The productivity number is secondary. The primary outcome is what your reviewers are doing with the time AXIOM returns to them. Edge cases. Ambiguous presentations. Peer-to-peer conversations where clinical judgment is the only thing in the room that matters.
Every decision is documented. Every clinical rationale is recorded. Every guideline application is auditable by default.
For Medical Directors specifically, reviewer productivity more than doubles from 15 to 20 cases per day to 35 to 45. The productivity number is secondary. The primary outcome is what your reviewers are doing with the time AXIOM returns to them. Edge cases. Ambiguous presentations. Peer-to-peer conversations where clinical judgment is the only thing in the room that matters.
The Real Risk Is an Operating Model That Has Reached Its Limit
The prior authorization crisis is a clinical operations problem that requires systems capable of genuine reasoning, real-time medical necessity evaluation, compliance at scale, and consistent, auditable decision-making.
Rohnium built AXIOM to work alongside clinical judgment, ensuring it is applied where it belongs, on the cases that actually need it.
And that patient from Monday morning, the one with moderate-to-severe rheumatoid arthritis, buried in a 34-page fax, waiting on her biologic approval? With AXIOM, her rheumatologist's office has the authorization before lunch. She starts therapy this week.
That is the outcome. That is the point.
Rohnium is a Global Data and AI Partner with offices in the USA and India. The AXIOM platform serves health plans across Medicare Advantage, Medicaid Managed Care, and commercial lines. Every engagement begins with a prior authorization workflow audit using your actual case volume, identifying the processing bottlenecks, compliance gaps, and reviewer capacity constraints your current operation is generating right now.
Talk to the Rohnium clinical AI team at www.rohnium.com.
Rohnium built AXIOM to work alongside clinical judgment, ensuring it is applied where it belongs, on the cases that actually need it.
And that patient from Monday morning, the one with moderate-to-severe rheumatoid arthritis, buried in a 34-page fax, waiting on her biologic approval? With AXIOM, her rheumatologist's office has the authorization before lunch. She starts therapy this week.
That is the outcome. That is the point.
Rohnium is a Global Data and AI Partner with offices in the USA and India. The AXIOM platform serves health plans across Medicare Advantage, Medicaid Managed Care, and commercial lines. Every engagement begins with a prior authorization workflow audit using your actual case volume, identifying the processing bottlenecks, compliance gaps, and reviewer capacity constraints your current operation is generating right now.
Talk to the Rohnium clinical AI team at www.rohnium.com.
